Biogen (BIIB)
(Real Time Quote from BATS)
$232.80 USD
-1.84 (-0.78%)
Updated Dec 4, 2023 02:30 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Detailed Estimates
Estimates
Exp Earnings Date | 2/21/24 |
---|---|
Current Quarter | 3.19 |
EPS Last Quarter | 4.36 |
Last EPS Surprise | 9.27% |
ABR | 1.53 |
Earnings ESP
|
-0.94% |
---|---|
Current Year | 14.95 |
Next Year | 15.77 |
EPS (TTM) | 15.83 |
P/E (F1) | 15.69 |
Sales Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.44B | 2.36B | 9.92B | 9.62B |
# of Estimates | 28 | 11 | 26 | 29 |
High Estimate | 2.56B | 2.48B | 10.06B | 10.44B |
Low Estimate | 2.25B | 2.21B | 9.70B | 8.61B |
Year ago Sales | 2.54B | 2.46B | 10.17B | 9.92B |
Year over Year Growth Est. | -3.98% | -4.16% | -2.52% | -3.00% |
Earnings Estimates
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.19 | 3.55 | 14.95 | 15.77 |
# of Estimates | 27 | 12 | 28 | 28 |
Most Recent Consensus | 3.09 | 3.65 | 14.87 | 14.98 |
High Estimate | 4.05 | 6.08 | 15.83 | 20.99 |
Low Estimate | 2.75 | 1.18 | 14.71 | 11.25 |
Year ago EPS | 4.05 | 3.40 | 17.67 | 14.95 |
Year over Year Growth Est. | -21.23% | 4.41% | -15.39% | 5.48% |
Agreement - Estimate Revisions
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 2 | 6 | 6 |
Up Last 60 Days | 0 | 2 | 5 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 24 | 8 | 19 | 19 |
Down Last 60 Days | 24 | 8 | 20 | 18 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Current | 3.19 | 3.55 | 14.95 | 15.77 |
7 Days Ago | 3.19 | 3.55 | 14.95 | 15.77 |
30 Days Ago | 3.89 | 3.82 | 15.27 | 16.59 |
60 Days Ago | 3.89 | 3.82 | 15.25 | 16.49 |
90 Days Ago | 3.89 | 3.81 | 15.25 | 16.49 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2023) |
Next Qtr (3/2024) |
Current Year (12/2023) |
Next Year (12/2024) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.16 | 3.55 | 14.96 | 15.79 |
Zacks Consensus Estimate | 3.19 | 3.55 | 14.95 | 15.77 |
Earnings ESP | -0.94% | 0.00% | 0.04% | 0.15% |
Surprise - Reported Earnings History
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Quarter Ending (12/2022) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 4.36 | 4.02 | 3.40 | 4.05 | NA |
Estimate | 3.99 | 3.77 | 3.25 | 3.51 | NA |
Difference | 0.37 | 0.25 | 0.15 | 0.54 | 0.33 |
Surprise | 9.27% | 6.63% | 4.62% | 15.38% | 8.98% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more